Fibromyalgia syndrome: A new paradigm for differential diagnosis and treatment

Journal of Manipulative and Physiological Therapeutics

Volumn 24, Issue 8, 2001, Pages 529-541

  Brady, David M ^a   Schneider, Michael J ^a  

^a UNIVERSITY OF BRIDGEPORT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CYANOCOBALAMIN; CYTOTOXIC AGENT; FOLIC ACID; IRON; LEVOTHYROXINE SODIUM; MONOAMINE OXIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; SEROTONIN UPTAKE INHIBITOR;

CYANOCOBALAMIN DEFICIENCY; DIFFERENTIAL DIAGNOSIS; FIBROMYALGIA; FOLIC ACID DEFICIENCY; HUMAN; HYPOTHYROIDISM; IRON DEFICIENCY ANEMIA; LABORATORY TEST; MUSCULOSKELETAL DISEASE; NOTE; SLEEP DISORDER; THYROID DISEASE;

EID: 0034765841     PISSN: 01614754     EISSN: None     Source Type: Journal    
DOI: 10.1067/mmt.2001.118202     Document Type: Article

References (61)

1. Induction of neurathenic musculoskeletal pain syndrome by selective sleep stage deprivation
2. Sleep and fibrositis syndrome
3. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia
4. Consensus document on fibromyaglia: The Copenhagen declaration
5. Muscle biopsy in fibromyalgia
6. A double-blind crossover trial of prednisone versus placebo in the treatment of fibrositis
7. A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia
8. Evaluation of amitriptyline in primary fibrositis
9. Clinical usefulness of amitriptyline in fibromyalgia: The results of 23 N-of-1 randomized, controlled trials
10. A comparison of cyclobenzaprine and placebo in the management of fibrositis
11. Neurochemical pathogenesis of fibromyalgia syndrome
12. A chronobiologic theory of fibromyalgia
13. Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome
14. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis
15. Serotonin (5HT) in serum and platelets from fibromyalgia patients and normal controls
16. Electron microscopic studies of muscle biopsy in primary fibromyalgia syndrome: A controlled and blinded study
17. Muscle biopsy in primary fibromyalgia: Light microscopic and histochemical findings
18. Comparative sensory evaluation of parietal tissues in painful and nonpainful areas in fibromyalgia and myofascial pain syndrome
19. Central hyperexcitability in fibromyalgia
20. Pain experience, psychological functioning and self-reported disability in chronic myofascial pain and fibromyalgia
21. The hypothalamic-pituitary-adrenal stress axis in the fibromyalgia syndrome
22. Patients with fibromyalgia in pain school
23. Cognitive behavioral treatment of fibromyalgia syndrome: A follow-up assessment
24. The impact of a meditation-based stress reduction program on fibromyalgia
25. Cognitive behavioral therapy for fibromyalgia
26. Fibromyalgia: A retrospective study of 252 consecutive referrals
27. EEG patterns and chronic fatigue syndrome
28. Fibromyalgia and its relation to chronic fatigue syndrome, viral illness, and immune abnormalities
29. Confounding features of fibromyalgia syndrome: A current perspective of differential diagnosis
30. Evaluation and differential diagnosis of fibromyalgia: Approach to diagnosis and management
31. Hypothyroidism presenting with musculoskeletal symptoms
32. Neuropathy, myopathy, and destructive arthropathy in primary hypothyroidism
33. Bilateral adhesive capsulitis, oligoarthritis, and proximal myopathy as presentation of hypothyroidism
34. The clinical presentation of hypothyroid myopathy and its relationship to abnormalities in structure and function of skeletal muscle
35. The thyroid: Physiology, thyrotoxicosis, hypothyroidism, and the painful thyroid
36. Fibromyalgia syndrome: An emerging but controversial condition
37. Management of fibromyalgia: Rationale for the use of magnesium and malic acid
38. Red blood cell magnesium and chronic fatigue syndrome
39. Citric, malic, and succinic acids as possible alternatives to deferoxamine in aluminum toxicity
40. Nutritional up-regulation of hepatic detoxification enzymes
41. Fibromyalgia, chronic pain, and the "leaky gut" syndrome
42. Allergic fatigue and toxemia
43. Metabolic toxicity and neuromuscular pain, joint disorders, and fibromyalgia
44. Tender points/fibromyalgia vs. tender points/myofascial pain syndrome: A need for clarity in terminology and differential diagnosis